163 related articles for article (PubMed ID: 12915882)
1. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk.
Gsur A; Zidek T; Schnattinger K; Feik E; Haidinger G; Hollaus P; Mohn-Staudner A; Armbruster C; Madersbacher S; Schatzl G; Trieb K; Vutuc C; Micksche M
Br J Cancer; 2003 Aug; 89(4):702-6. PubMed ID: 12915882
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis.
Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T
Tumori; 2010; 96(5):756-63. PubMed ID: 21302624
[TBL] [Abstract][Full Text] [Related]
3. Association between lung cancer and microsomal epoxide hydrolase genotypes.
Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A
Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050
[TBL] [Abstract][Full Text] [Related]
4. Detection of polymorphisms at exons 3 (Tyr113-->His) and 4 (His139-->Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis.
Rodriguez F; Jardi R; Costa X; Juan D; Galimany R; Vidal R; Miravitlles M
Anal Biochem; 2002 Sep; 308(1):120-6. PubMed ID: 12234472
[TBL] [Abstract][Full Text] [Related]
5. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review.
Lee WJ; Brennan P; Boffetta P; London SJ; Benhamou S; Rannug A; To-Figueras J; Ingelman-Sundberg M; Shields P; Gaspari L; Taioli E
Biomarkers; 2002; 7(3):230-41. PubMed ID: 12141066
[TBL] [Abstract][Full Text] [Related]
6. Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene.
Abdel-Rahman SZ; El-Zein RA; Ammenheuser MM; Yang Z; Stock TH; Morandi M; Ward JB
Environ Mol Mutagen; 2003; 41(2):140-6. PubMed ID: 12605384
[TBL] [Abstract][Full Text] [Related]
7. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
[TBL] [Abstract][Full Text] [Related]
8. Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer.
Baxter SW; Choong DY; Campbell IG
Cancer Lett; 2002 Mar; 177(1):75-81. PubMed ID: 11809533
[TBL] [Abstract][Full Text] [Related]
9. Possible role of microsomal epoxide hydrolase gene polymorphism as a risk factor for developing insulin resistance and type 2 diabetes mellitus.
Ghattas MH; Amer MA
Endocrine; 2012 Dec; 42(3):577-83. PubMed ID: 22555758
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the
Walia HK; Singh N; Sharma S
Future Oncol; 2021 Dec; 17(35):4925-4946. PubMed ID: 34672683
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
[TBL] [Abstract][Full Text] [Related]
15. Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.
Sivonova MK; Dobrota D; Matakova T; Dusenka R; Grobarcikova S; Habala V; Salagovic J; Tajtakova M; Pidanicova A; Valansky L; Lachvacs L; Kliment J; Nagy V; Kliment J
Neoplasma; 2012; 59(1):79-84. PubMed ID: 22103900
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer.
Watanabe J; Shimada T; Gillam EM; Ikuta T; Suemasu K; Higashi Y; Gotoh O; Kawajiri K
Pharmacogenetics; 2000 Feb; 10(1):25-33. PubMed ID: 10739169
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer.
Mittal RD; Srivastava DL
DNA Cell Biol; 2007 Nov; 26(11):791-8. PubMed ID: 17919073
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Corbella J
Cancer Lett; 2001 Nov; 173(2):155-62. PubMed ID: 11597790
[TBL] [Abstract][Full Text] [Related]
19. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
